CLAIM CARD
_Within the currently bound receipt bundle, no A_core/B_context opposing fact was selected. Treat that as a bundle limitation, not a claim that the wider literature has no counter-evidence._
Evidence grade: exploratory
Contradiction status: none
Publication: 48abac66-87ee-46dd-a1e0-1a1bbcc8d12d
Provenance: Derivation Web chain
Citation Support
source_1Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restrictionsource_2Rapamycin fed late in life extends lifespan in genetically heterogeneous micesource_3Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducersource_4Transient rapamycin treatment can increase lifespan and healthspan in middle-aged micesource_5Life-span Extension Drug Interventions Affect Adipose Tissue Inflammation in Aging